Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15081648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cardiac Valve Complications in Prolactinomas Treated With Cabergoline
Condition: Prolactinomas
Intervention: Drug: Cabergoline

Indicates status has not been verified in more than two years